img

Global Trastuzumab Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Trastuzumab Market Insights, Forecast to 2034

Trastuzumab, a monoclonal antibody against Her2, blocks the growth of cancer cells by attaching itself to Her2, preventing epidermal growth factor from attaching to Her2. Herceptin also stimulates the body's own immune cells to destroy cancer cells. Clinically, it is mainly used for metastatic breast cancer with excessive expression of her-2. Monotherapy may be used for metastatic breast cancer that has received one or more chemotherapy regimens; It can be combined with paclitaxel to treat metastatic breast cancer without chemotherapy.
Global Trastuzumab market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Trastuzumab industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Trastuzumab is a monoclonal antibody used in breast cancer therapy. Market trends include the expansion of its use in adjuvant and neoadjuvant settings, as well as research into biosimilars to improve affordability and accessibility.
Report Covers
This report presents an overview of global Trastuzumab market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Trastuzumab market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Genentech Inc
Novartis AG
Pfizer
Abnova Corporation
InvivoGen
Celltrion
Biocon Limited
Bio-Techne
Segment by Type
Human Source
Animal Source

Segment by Application


Hospital
Medical Center

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Trastuzumab plant distribution, commercial date of Trastuzumab, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Trastuzumab introduction, etc. Trastuzumab Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Trastuzumab
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Trastuzumab Product Introduction
1.2 Market by Type
1.2.1 Global Trastuzumab Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Human Source
1.2.3 Animal Source
1.3 Market by Application
1.3.1 Global Trastuzumab Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Medical Center
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Trastuzumab Sales Estimates and Forecasts 2018-2029
2.2 Global Trastuzumab Revenue by Region
2.2.1 Global Trastuzumab Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Trastuzumab Revenue by Region (2018-2024)
2.2.3 Global Trastuzumab Revenue by Region (2024-2029)
2.2.4 Global Trastuzumab Revenue Market Share by Region (2018-2029)
2.3 Global Trastuzumab Sales Estimates and Forecasts 2018-2029
2.4 Global Trastuzumab Sales by Region
2.4.1 Global Trastuzumab Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Trastuzumab Sales by Region (2018-2024)
2.4.3 Global Trastuzumab Sales by Region (2024-2029)
2.4.4 Global Trastuzumab Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Trastuzumab Sales by Manufacturers
3.1.1 Global Trastuzumab Sales by Manufacturers (2018-2024)
3.1.2 Global Trastuzumab Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Trastuzumab in 2022
3.2 Global Trastuzumab Revenue by Manufacturers
3.2.1 Global Trastuzumab Revenue by Manufacturers (2018-2024)
3.2.2 Global Trastuzumab Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Trastuzumab Revenue in 2022
3.3 Global Key Players of Trastuzumab, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Trastuzumab Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Trastuzumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Trastuzumab, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Trastuzumab, Product Offered and Application
3.8 Global Key Manufacturers of Trastuzumab, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Trastuzumab Sales by Type
4.1.1 Global Trastuzumab Historical Sales by Type (2018-2024)
4.1.2 Global Trastuzumab Forecasted Sales by Type (2024-2029)
4.1.3 Global Trastuzumab Sales Market Share by Type (2018-2029)
4.2 Global Trastuzumab Revenue by Type
4.2.1 Global Trastuzumab Historical Revenue by Type (2018-2024)
4.2.2 Global Trastuzumab Forecasted Revenue by Type (2024-2029)
4.2.3 Global Trastuzumab Revenue Market Share by Type (2018-2029)
4.3 Global Trastuzumab Price by Type
4.3.1 Global Trastuzumab Price by Type (2018-2024)
4.3.2 Global Trastuzumab Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Trastuzumab Sales by Application
5.1.1 Global Trastuzumab Historical Sales by Application (2018-2024)
5.1.2 Global Trastuzumab Forecasted Sales by Application (2024-2029)
5.1.3 Global Trastuzumab Sales Market Share by Application (2018-2029)
5.2 Global Trastuzumab Revenue by Application
5.2.1 Global Trastuzumab Historical Revenue by Application (2018-2024)
5.2.2 Global Trastuzumab Forecasted Revenue by Application (2024-2029)
5.2.3 Global Trastuzumab Revenue Market Share by Application (2018-2029)
5.3 Global Trastuzumab Price by Application
5.3.1 Global Trastuzumab Price by Application (2018-2024)
5.3.2 Global Trastuzumab Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Trastuzumab Market Size by Type
6.1.1 US & Canada Trastuzumab Sales by Type (2018-2029)
6.1.2 US & Canada Trastuzumab Revenue by Type (2018-2029)
6.2 US & Canada Trastuzumab Market Size by Application
6.2.1 US & Canada Trastuzumab Sales by Application (2018-2029)
6.2.2 US & Canada Trastuzumab Revenue by Application (2018-2029)
6.3 US & Canada Trastuzumab Market Size by Country
6.3.1 US & Canada Trastuzumab Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Trastuzumab Sales by Country (2018-2029)
6.3.3 US & Canada Trastuzumab Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Trastuzumab Market Size by Type
7.1.1 Europe Trastuzumab Sales by Type (2018-2029)
7.1.2 Europe Trastuzumab Revenue by Type (2018-2029)
7.2 Europe Trastuzumab Market Size by Application
7.2.1 Europe Trastuzumab Sales by Application (2018-2029)
7.2.2 Europe Trastuzumab Revenue by Application (2018-2029)
7.3 Europe Trastuzumab Market Size by Country
7.3.1 Europe Trastuzumab Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Trastuzumab Sales by Country (2018-2029)
7.3.3 Europe Trastuzumab Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Trastuzumab Market Size
8.1.1 China Trastuzumab Sales (2018-2029)
8.1.2 China Trastuzumab Revenue (2018-2029)
8.2 China Trastuzumab Market Size by Application
8.2.1 China Trastuzumab Sales by Application (2018-2029)
8.2.2 China Trastuzumab Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Trastuzumab Market Size by Type
9.1.1 Asia Trastuzumab Sales by Type (2018-2029)
9.1.2 Asia Trastuzumab Revenue by Type (2018-2029)
9.2 Asia Trastuzumab Market Size by Application
9.2.1 Asia Trastuzumab Sales by Application (2018-2029)
9.2.2 Asia Trastuzumab Revenue by Application (2018-2029)
9.3 Asia Trastuzumab Sales by Region
9.3.1 Asia Trastuzumab Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Trastuzumab Revenue by Region (2018-2029)
9.3.3 Asia Trastuzumab Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Trastuzumab Market Size by Type
10.1.1 Middle East, Africa and Latin America Trastuzumab Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Trastuzumab Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Trastuzumab Market Size by Application
10.2.1 Middle East, Africa and Latin America Trastuzumab Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Trastuzumab Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Trastuzumab Sales by Country
10.3.1 Middle East, Africa and Latin America Trastuzumab Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Trastuzumab Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Trastuzumab Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Genentech Inc
11.1.1 Genentech Inc Company Information
11.1.2 Genentech Inc Overview
11.1.3 Genentech Inc Trastuzumab Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Genentech Inc Trastuzumab Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Genentech Inc Recent Developments
11.2 Novartis AG
11.2.1 Novartis AG Company Information
11.2.2 Novartis AG Overview
11.2.3 Novartis AG Trastuzumab Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Novartis AG Trastuzumab Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novartis AG Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Overview
11.3.3 Pfizer Trastuzumab Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Pfizer Trastuzumab Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pfizer Recent Developments
11.4 Abnova Corporation
11.4.1 Abnova Corporation Company Information
11.4.2 Abnova Corporation Overview
11.4.3 Abnova Corporation Trastuzumab Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Abnova Corporation Trastuzumab Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Abnova Corporation Recent Developments
11.5 InvivoGen
11.5.1 InvivoGen Company Information
11.5.2 InvivoGen Overview
11.5.3 InvivoGen Trastuzumab Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 InvivoGen Trastuzumab Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 InvivoGen Recent Developments
11.6 Celltrion
11.6.1 Celltrion Company Information
11.6.2 Celltrion Overview
11.6.3 Celltrion Trastuzumab Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Celltrion Trastuzumab Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Celltrion Recent Developments
11.7 Biocon Limited
11.7.1 Biocon Limited Company Information
11.7.2 Biocon Limited Overview
11.7.3 Biocon Limited Trastuzumab Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Biocon Limited Trastuzumab Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Biocon Limited Recent Developments
11.8 Bio-Techne
11.8.1 Bio-Techne Company Information
11.8.2 Bio-Techne Overview
11.8.3 Bio-Techne Trastuzumab Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Bio-Techne Trastuzumab Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bio-Techne Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Trastuzumab Industry Chain Analysis
12.2 Trastuzumab Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Trastuzumab Production Mode & Process
12.4 Trastuzumab Sales and Marketing
12.4.1 Trastuzumab Sales Channels
12.4.2 Trastuzumab Distributors
12.5 Trastuzumab Customers
13 Market Dynamics
13.1 Trastuzumab Industry Trends
13.2 Trastuzumab Market Drivers
13.3 Trastuzumab Market Challenges
13.4 Trastuzumab Market Restraints
14 Key Findings in The Global Trastuzumab Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Trastuzumab Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Human Source
Table 3. Major Manufacturers of Animal Source
Table 4. Global Trastuzumab Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Trastuzumab Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Trastuzumab Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Trastuzumab Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Trastuzumab Revenue Market Share by Region (2018-2024)
Table 9. Global Trastuzumab Revenue Market Share by Region (2024-2029)
Table 10. Global Trastuzumab Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Trastuzumab Sales by Region (2018-2024) & (MT)
Table 12. Global Trastuzumab Sales by Region (2024-2029) & (MT)
Table 13. Global Trastuzumab Sales Market Share by Region (2018-2024)
Table 14. Global Trastuzumab Sales Market Share by Region (2024-2029)
Table 15. Global Trastuzumab Sales by Manufacturers (2018-2024) & (MT)
Table 16. Global Trastuzumab Sales Share by Manufacturers (2018-2024)
Table 17. Global Trastuzumab Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Trastuzumab Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Trastuzumab, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Trastuzumab Price by Manufacturers 2018-2024 (USD/MT)
Table 21. Global Trastuzumab Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Trastuzumab by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Trastuzumab as of 2022)
Table 23. Global Key Manufacturers of Trastuzumab, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Trastuzumab, Product Offered and Application
Table 25. Global Key Manufacturers of Trastuzumab, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Trastuzumab Sales by Type (2018-2024) & (MT)
Table 28. Global Trastuzumab Sales by Type (2024-2029) & (MT)
Table 29. Global Trastuzumab Sales Share by Type (2018-2024)
Table 30. Global Trastuzumab Sales Share by Type (2024-2029)
Table 31. Global Trastuzumab Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Trastuzumab Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Trastuzumab Revenue Share by Type (2018-2024)
Table 34. Global Trastuzumab Revenue Share by Type (2024-2029)
Table 35. Trastuzumab Price by Type (2018-2024) & (USD/MT)
Table 36. Global Trastuzumab Price Forecast by Type (2024-2029) & (USD/MT)
Table 37. Global Trastuzumab Sales by Application (2018-2024) & (MT)
Table 38. Global Trastuzumab Sales by Application (2024-2029) & (MT)
Table 39. Global Trastuzumab Sales Share by Application (2018-2024)
Table 40. Global Trastuzumab Sales Share by Application (2024-2029)
Table 41. Global Trastuzumab Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Trastuzumab Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Trastuzumab Revenue Share by Application (2018-2024)
Table 44. Global Trastuzumab Revenue Share by Application (2024-2029)
Table 45. Trastuzumab Price by Application (2018-2024) & (USD/MT)
Table 46. Global Trastuzumab Price Forecast by Application (2024-2029) & (USD/MT)
Table 47. US & Canada Trastuzumab Sales by Type (2018-2024) & (MT)
Table 48. US & Canada Trastuzumab Sales by Type (2024-2029) & (MT)
Table 49. US & Canada Trastuzumab Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Trastuzumab Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Trastuzumab Sales by Application (2018-2024) & (MT)
Table 52. US & Canada Trastuzumab Sales by Application (2024-2029) & (MT)
Table 53. US & Canada Trastuzumab Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Trastuzumab Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Trastuzumab Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Trastuzumab Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Trastuzumab Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Trastuzumab Sales by Country (2018-2024) & (MT)
Table 59. US & Canada Trastuzumab Sales by Country (2024-2029) & (MT)
Table 60. Europe Trastuzumab Sales by Type (2018-2024) & (MT)
Table 61. Europe Trastuzumab Sales by Type (2024-2029) & (MT)
Table 62. Europe Trastuzumab Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Trastuzumab Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Trastuzumab Sales by Application (2018-2024) & (MT)
Table 65. Europe Trastuzumab Sales by Application (2024-2029) & (MT)
Table 66. Europe Trastuzumab Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Trastuzumab Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Trastuzumab Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Trastuzumab Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Trastuzumab Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Trastuzumab Sales by Country (2018-2024) & (MT)
Table 72. Europe Trastuzumab Sales by Country (2024-2029) & (MT)
Table 73. China Trastuzumab Sales by Type (2018-2024) & (MT)
Table 74. China Trastuzumab Sales by Type (2024-2029) & (MT)
Table 75. China Trastuzumab Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Trastuzumab Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Trastuzumab Sales by Application (2018-2024) & (MT)
Table 78. China Trastuzumab Sales by Application (2024-2029) & (MT)
Table 79. China Trastuzumab Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Trastuzumab Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Trastuzumab Sales by Type (2018-2024) & (MT)
Table 82. Asia Trastuzumab Sales by Type (2024-2029) & (MT)
Table 83. Asia Trastuzumab Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Trastuzumab Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Trastuzumab Sales by Application (2018-2024) & (MT)
Table 86. Asia Trastuzumab Sales by Application (2024-2029) & (MT)
Table 87. Asia Trastuzumab Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Trastuzumab Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Trastuzumab Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Trastuzumab Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Trastuzumab Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Trastuzumab Sales by Region (2018-2024) & (MT)
Table 93. Asia Trastuzumab Sales by Region (2024-2029) & (MT)
Table 94. Middle East, Africa and Latin America Trastuzumab Sales by Type (2018-2024) & (MT)
Table 95. Middle East, Africa and Latin America Trastuzumab Sales by Type (2024-2029) & (MT)
Table 96. Middle East, Africa and Latin America Trastuzumab Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Trastuzumab Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Trastuzumab Sales by Application (2018-2024) & (MT)
Table 99. Middle East, Africa and Latin America Trastuzumab Sales by Application (2024-2029) & (MT)
Table 100. Middle East, Africa and Latin America Trastuzumab Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Trastuzumab Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Trastuzumab Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Trastuzumab Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Trastuzumab Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Trastuzumab Sales by Country (2018-2024) & (MT)
Table 106. Middle East, Africa and Latin America Trastuzumab Sales by Country (2024-2029) & (MT)
Table 107. Genentech Inc Company Information
Table 108. Genentech Inc Description and Major Businesses
Table 109. Genentech Inc Trastuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 110. Genentech Inc Trastuzumab Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Genentech Inc Recent Developments
Table 112. Novartis AG Company Information
Table 113. Novartis AG Description and Major Businesses
Table 114. Novartis AG Trastuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 115. Novartis AG Trastuzumab Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Novartis AG Recent Developments
Table 117. Pfizer Company Information
Table 118. Pfizer Description and Major Businesses
Table 119. Pfizer Trastuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 120. Pfizer Trastuzumab Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Pfizer Recent Developments
Table 122. Abnova Corporation Company Information
Table 123. Abnova Corporation Description and Major Businesses
Table 124. Abnova Corporation Trastuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 125. Abnova Corporation Trastuzumab Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Abnova Corporation Recent Developments
Table 127. InvivoGen Company Information
Table 128. InvivoGen Description and Major Businesses
Table 129. InvivoGen Trastuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 130. InvivoGen Trastuzumab Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. InvivoGen Recent Developments
Table 132. Celltrion Company Information
Table 133. Celltrion Description and Major Businesses
Table 134. Celltrion Trastuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 135. Celltrion Trastuzumab Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Celltrion Recent Developments
Table 137. Biocon Limited Company Information
Table 138. Biocon Limited Description and Major Businesses
Table 139. Biocon Limited Trastuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 140. Biocon Limited Trastuzumab Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Biocon Limited Recent Developments
Table 142. Bio-Techne Company Information
Table 143. Bio-Techne Description and Major Businesses
Table 144. Bio-Techne Trastuzumab Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 145. Bio-Techne Trastuzumab Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Bio-Techne Recent Developments
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Trastuzumab Distributors List
Table 150. Trastuzumab Customers List
Table 151. Trastuzumab Market Trends
Table 152. Trastuzumab Market Drivers
Table 153. Trastuzumab Market Challenges
Table 154. Trastuzumab Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Trastuzumab Product Picture
Figure 2. Global Trastuzumab Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Trastuzumab Market Share by Type in 2022 & 2029
Figure 4. Human Source Product Picture
Figure 5. Animal Source Product Picture
Figure 6. Global Trastuzumab Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Trastuzumab Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Medical Center
Figure 10. Trastuzumab Report Years Considered
Figure 11. Global Trastuzumab Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Trastuzumab Revenue 2018-2029 (US$ Million)
Figure 13. Global Trastuzumab Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Trastuzumab Revenue Market Share by Region (2018-2029)
Figure 15. Global Trastuzumab Sales 2018-2029 ((MT)
Figure 16. Global Trastuzumab Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Trastuzumab Sales YoY (2018-2029) & (MT)
Figure 18. US & Canada Trastuzumab Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Trastuzumab Sales YoY (2018-2029) & (MT)
Figure 20. Europe Trastuzumab Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Trastuzumab Sales YoY (2018-2029) & (MT)
Figure 22. China Trastuzumab Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Trastuzumab Sales YoY (2018-2029) & (MT)
Figure 24. Asia (excluding China) Trastuzumab Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Trastuzumab Sales YoY (2018-2029) & (MT)
Figure 26. Middle East, Africa and Latin America Trastuzumab Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Trastuzumab Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Trastuzumab in the World: Market Share by Trastuzumab Revenue in 2022
Figure 29. Global Trastuzumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Trastuzumab Sales Market Share by Type (2018-2029)
Figure 31. Global Trastuzumab Revenue Market Share by Type (2018-2029)
Figure 32. Global Trastuzumab Sales Market Share by Application (2018-2029)
Figure 33. Global Trastuzumab Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Trastuzumab Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Trastuzumab Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Trastuzumab Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Trastuzumab Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Trastuzumab Revenue Share by Country (2018-2029)
Figure 39. US & Canada Trastuzumab Sales Share by Country (2018-2029)
Figure 40. U.S. Trastuzumab Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Trastuzumab Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Trastuzumab Sales Market Share by Type (2018-2029)
Figure 43. Europe Trastuzumab Revenue Market Share by Type (2018-2029)
Figure 44. Europe Trastuzumab Sales Market Share by Application (2018-2029)
Figure 45. Europe Trastuzumab Revenue Market Share by Application (2018-2029)
Figure 46. Europe Trastuzumab Revenue Share by Country (2018-2029)
Figure 47. Europe Trastuzumab Sales Share by Country (2018-2029)
Figure 48. Germany Trastuzumab Revenue (2018-2029) & (US$ Million)
Figure 49. France Trastuzumab Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Trastuzumab Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Trastuzumab Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Trastuzumab Revenue (2018-2029) & (US$ Million)
Figure 53. China Trastuzumab Sales Market Share by Type (2018-2029)
Figure 54. China Trastuzumab Revenue Market Share by Type (2018-2029)
Figure 55. China Trastuzumab Sales Market Share by Application (2018-2029)
Figure 56. China Trastuzumab Revenue Market Share by Application (2018-2029)
Figure 57. Asia Trastuzumab Sales Market Share by Type (2018-2029)
Figure 58. Asia Trastuzumab Revenue Market Share by Type (2018-2029)
Figure 59. Asia Trastuzumab Sales Market Share by Application (2018-2029)
Figure 60. Asia Trastuzumab Revenue Market Share by Application (2018-2029)
Figure 61. Asia Trastuzumab Revenue Share by Region (2018-2029)
Figure 62. Asia Trastuzumab Sales Share by Region (2018-2029)
Figure 63. Japan Trastuzumab Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Trastuzumab Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Trastuzumab Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Trastuzumab Revenue (2018-2029) & (US$ Million)
Figure 67. India Trastuzumab Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Trastuzumab Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Trastuzumab Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Trastuzumab Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Trastuzumab Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Trastuzumab Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Trastuzumab Sales Share by Country (2018-2029)
Figure 74. Brazil Trastuzumab Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Trastuzumab Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Trastuzumab Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Trastuzumab Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Trastuzumab Revenue (2018-2029) & (US$ Million)
Figure 79. Trastuzumab Value Chain
Figure 80. Trastuzumab Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed